tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Myriad Genetics Updates 2025 Revenue Guidance Amid Growth
PremiumCompany AnnouncementsMyriad Genetics Updates 2025 Revenue Guidance Amid Growth
22d ago
Hold Rating Maintained for Myriad Genetics Amid Mixed Performance and Strategic Challenges
Premium
Ratings
Hold Rating Maintained for Myriad Genetics Amid Mixed Performance and Strategic Challenges
22d ago
Myriad Genetics reports Q2 adjusted EPS 5c, consensus (1c)
Premium
The Fly
Myriad Genetics reports Q2 adjusted EPS 5c, consensus (1c)
23d ago
Balancing Optimism and Caution: Hold Rating for Myriad Genetics Amid Strategic Shifts and Uncertainties
PremiumRatingsBalancing Optimism and Caution: Hold Rating for Myriad Genetics Amid Strategic Shifts and Uncertainties
3M ago
Myriad Genetics announces early access to FirstGene Multiple Prenatal Screen
Premium
The Fly
Myriad Genetics announces early access to FirstGene Multiple Prenatal Screen
3M ago
Myriad Genetics shares MRD data from MONSTAR-SCREEN 3 study
Premium
The Fly
Myriad Genetics shares MRD data from MONSTAR-SCREEN 3 study
3M ago
Myriad Genetics price target lowered to $4 from $9 at BofA
PremiumThe FlyMyriad Genetics price target lowered to $4 from $9 at BofA
3M ago
Myriad Genetics price target lowered to $7 from $16 at Morgan Stanley
Premium
The Fly
Myriad Genetics price target lowered to $7 from $16 at Morgan Stanley
3M ago
Myriad Genetics price target lowered to $9 from $12.50 at Piper Sandler
Premium
The Fly
Myriad Genetics price target lowered to $9 from $12.50 at Piper Sandler
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100